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Research
Jet propulsion fuel 8 (JP-8) has been recog-
nized as a major source of chemical exposure
for fuel-cell maintenance workers [Agency for
Toxic Substances and Disease Registry
(ATSDR) 1998; National Research Council
2003]. Despite the increasing number of stud-
ies conducted on JP-8 (Carlton and Smith
2000; Egeghy et al. 2003; Pleil et al. 2000;
Rhodes et al. 2003; Serdar et al. 2003),
knowledge of JP-8 exposure, uptake, metabo-
lism, and its potential effects on human health
is limited, and only one study has been pub-
lished on the quantiﬁcation and assessment of
JP-8 dermal exposure (Chao et al. 2005).
Previous studies on JP-8 exposure have
emphasized the potential contribution of der-
mal exposure to increased biomarker levels
(i.e., urinary 1- and 2-naphthol) based on sur-
rogate factors used as indicators of dermal
exposure (e.g., skin irritation, work inside the
fuel cell, cleaning fuel puddles) (Egeghy et al.
2003; Serdar et al. 2004). To our knowledge,
exposure to JP-8 and the contributions of the
different exposure routes (i.e., inhalation and
dermal) to the total body dose have not been
quantitatively investigated.
In this study, we examined the contribu-
tions of dermal and inhalation exposure to
naphthalene, as a marker for JP-8 exposure
(Chao et al. 2005; Chao and Nylander-French
2004; Egeghy et al. 2003; Serdar et al. 2003,
2004), to the levels of urinary 1-naphthol and
2-naphthol in U.S. Air Force (USAF) fuel-cell
maintenance workers. We demonstrate, using
multiple linear regression analyses, that both
dermal and inhalation exposure to JP-8 signiﬁ-
cantly contribute to urinary 1-naphthol and
2-naphthol levels. The relative contributions of
both exposure routes to the total body dose
were also estimated.
Materials and Methods
Study population. This study was conducted
at six USAF bases, as a part of a broader pro-
ject (Institute of Environmental and Human
Health 2001), to investigate the relative con-
tributions of JP-8 exposures through different
routes (i.e., inhalation and dermal) to the total
body dose of fuel-cell maintenance workers.
Workers were recruited with informed con-
sent from active-duty USAF personnel who
routinely worked with, or were exposed to,
JP-8. Although 339 USAF personnel were
enrolled in the overall project, a total of
85 fuel-cell maintenance workers were
included in our particular study. Approval for
human subject use was obtained from the
institutional review board for each of the par-
ticipating investigators and for the USAF, and
the study complied with all applicable U.S.
requirements and regulations.
Questionnaires were collected after the
work shift to obtain information on demo-
graphic factors, including job tasks, the use of
personal protective equipment, smoking status,
and other work-related characteristics. Work
diaries for each individual were also recorded
during the survey, including detailed informa-
tion on work tasks, task durations, and the use
of personal protective equipment. Workers
included in this study entered fuel cells during
the day sampling was conducted. They per-
formed maintenance work inside the fuel cell
and thus were expected to have the highest
potential for both dermal and inhalation expo-
sure to JP-8. To reduce inhalation exposure, all
workers wore air-supplied respirators when
working inside the fuel cell. Although USAF
personnel had been assigned a priori into expo-
sure groups (Egeghy et al. 2003; Serdar et al.
2004), we note that these categories did not
fully correspond with the work scenarios given
in the work diaries on the day of investigation.
Therefore, in the present investigation we
relied upon the work diaries to deﬁne job tasks
and work scenarios.
Sample collection and analysis. Dermal
samples. Collection and analyses of tape-strip
samples have been described previously (Chao
et al. 2005). Briefly, for each worker, three
body regions with potentially the greatest JP-8
exposure were selected for dermal sampling.
Tape-strip samples were collected with Cover-
Roll (Beiersdorf AG, Germany) tape at each
exposed body location, three locations total,
after the work shift. For each worker, body
regions sampled included three of the following
body parts: forehead, neck, shoulders, arms,
hands, legs, knees, feet, and buttocks. Samples
were analyzed by gas chromatography–mass
spectrometry (GC-MS) (Chao and Nylander-
French 2004). The amount of naphthalene
removed with the three successive tape-strip
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particular region sampled in order to estimate
the regional dermal exposure to naphthalene.
For each worker, the regional surface areas were
estimated by the Lund and Browder chart
(Deitch 1999) and by Haycock’s formula
(Haycock et al. 1978). The whole-body dermal
exposure (nanograms per square meter) was cal-
culated by summing the estimated regional der-
mal naphthalene concentrations of the three
sampled regions (e.g., arm, neck, and leg) and
by conservatively assuming that no exposure to
the other unsampled regions occurred.
Breathing-zone, breath, and urine sam-
ples. Personal inhalation exposure to naphtha-
lene was monitored during the 4-hr work shift
with passive monitors attached to the workers’
shirt collars. Exhaled-breath samples were col-
lected using 75-cm3 glass bulbs before and after
the work shift inside the hangar (Egeghy et al.
2003). Sampling and analyses of breathing-
zone and breath samples have been described
previously (Egeghy et al. 2003). Brieﬂy, breath
samples were passively transferred from the
glass bulbs to Tenax (SKC Inc., Eighty Four,
PA) tubes before analysis. Both breathing-
zone air and breath samples were analyzed by
thermal desorption followed by GC-MS with
photo ionization detection.
Both 1-naphthol and 2-naphthol concen-
trations were determined from urine samples
collected from each worker before and after the
work shift. Collection and analyses of urine
samples have been described elsewhere (Serdar
et al. 2003). Brieﬂy, 2 mL urine was brought
to room temperature and 50 µL hexane solu-
tion containing 1 µg/mL 1-naphthol-d7
(internal standard) was added. The sample
was hydrolyzed with β-glucuronidase/sulfa-
tase and extracted twice with a total of 7 mL
ethyl acetate. After evaporation under nitro-
gen, the residue was derivatized with Tri-Sil
TBT (Pierce, Rockford, IL) in hexane. The
trimethylsilyl ether derivatives were then ana-
lyzed by GC-MS in single-ion monitoring
mode.
Statistical analyses. All exposure data (der-
mal, breathing-zone air, breath, and urine)
were natural log-transformed to help satisfy
assumptions regarding normality and homoge-
neous variance. Paired analyses were performed
to investigate the differences between pre- and
postexposure measurements of breath naphtha-
lene and urinary 1- and 2-naphthol levels, as
well as between postexposure urinary 1- and
2-naphthol levels. Multiple linear regression
analysis (Proc REG procedure in SAS, version
8.2; SAS Institute, Cary, NC) was used to
investigate the contributions of JP-8 exposure
(dermal and inhalation), smoking, and other
covariates obtained from questionnaires to uri-
nary 1- and 2-naphthol concentrations.
Stepwise variable selection was used to deter-
mine final regression models, with inclusion
and elimination decisions about predictors
conducted at the α = 0.10 level. Possible
collinearity problems were investigated using
eigenvalue analyses and variance inﬂation fac-
tors. Possible outliers were examined using stu-
dentized residuals. All statistical analyses were
performed using SAS software.
The multiple linear regression model
structure adopted was of the general form:
Here, the outcome variable ln(urinary
naphtholi) [ln(ng/L)] is the natural logarithm
of either the ith worker’s urinary 1-naphthol
or urinary 2-naphthol level; Xij represents the
ith worker’s jth exposure level to JP-8 (der-
mal, breathing-zone, or breath naphthalene
measurement); and Cik represents the kth
covariate value for the ith worker based on
questionnaires providing information on
smoking status (38 smokers, 47 nonsmokers),
race (74 white, 11 nonwhite), sex (81 males,
4 females), job tasks [handle foams (n = 73),
hold ventilation (n = 58), remove bolts
(n = 55), remove foams (n = 76), remove tank
door (n = 63)], and so forth.
The predictor variable effects consisted of
α, the intercept; βj, the regression coefﬁcient
for the natural logarithm of JP-8 exposure
{e.g., the natural logarithm of dermal naph-
thalene [ln(ng/m2)], breathing-zone or breath
naphthalene [ln(ng/m3)]}; and γk, the regres-
sion coefficient for covariate k. Two models
were ﬁtted using different inhalation markers.
We used the breathing-zone naphthalene level
in model 1 and the end-exhaled breath naph-
thalene level in model 2 as inhalation markers.
The relative contributions of predictor
variables in the final regression models were
determined by the proportionate contribution
that each predictor made to the regression
model multiple R2 using the Pratt index (Pratt
1987). For each predictor in a ﬁnal regression
model, the Pratt index for that predictor is the
product of its estimated standardized regression
coefﬁcient and the simple correlation between
that predictor and the outcome variable. One
particularly nice property of the Pratt index is
that the sum of the Pratt indices for all predic-
tors equals R2. The Pratt index for each predic-
tor can be rescaled by dividing it by the model
R2 and multiplying by 100, so that the result-
ing number can be interpreted as the percent-
age of the model R2 accounted for by that
predictor.
Results
Exposure measurements. The measured der-
mal, breathing-zone, and breath naphthalene
levels, as well as urinary 1- and 2-naphthol
levels, for the 85 USAF fuel-cell maintenance
workers are described in Table 1. The geo-
metric mean (GM) [geometric standard
deviation (GSD)] of dermal naphthalene level
were 4,180 (9.35 ng/m2) with a range of
100 ng/m2 to 5,090 µg/m2. The GM (GSD)
of breathing-zone naphthalene were 614,000
and (2.12 ng/m3) with a range of 670 ng/m3
to 3,910 µg/m3. The postexposure levels of
breath naphthalene and urinary 1- and
2-naphthol were signiﬁcantly higher than the
preexposure levels (all p-values < 0.0001). In
addition, postexposure urinary 2-naphthol
levels were greater than postexposure urinary
1-naphthol levels (p < 0.0001).
Regression analysis for urinary naphthol
levels using breathing-zone naphthalene as an
inhalation marker (model 1). Model 1
explained 26.6% and 26.3% of total variance
in the urinary 1- and 2-naphthol levels in
entrants, respectively (Table 2). In the model
for urinary 1-naphthol, breathing-zone naph-
thalene and smoking were the only signiﬁcant
predictors, explaining 88.2% and 11.8% of
total variance, respectively, using the Pratt
index of relative importance (Pratt 1987). For
urinary 2-naphthol, dermal and breathing-zone
naphthalene and smoking were significant,
explaining 51.1%, 35.8%, and 13.1% of total
variance, respectively. These results indicate
that dermal exposure to naphthalene con-
tributed significantly to urinary 2-naphthol
levels but not to urinary 1-naphthol levels
among the fuel-cell maintenance workers.
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Table 1. GMs and GSDs of dermal, breathing-zone, and breath naphthalene and urinary 1- and 2-naphthol
levels observed in USAF fuel-cell maintenance workers. 
Indicator of exposure No. GM GSD Minimum Maximum
Dermal naphthalene (ng/m2) 85 4,180 9.35 100 5,090,000
Breathing-zone naphthalene (ng/m3) 83 614,000 2.21 670 3,910,000
Preexposure breath naphthalene (ng/m3) 82 492 1.99 330 16,100
Breath naphthalene (ng/m3) 72 9,230a 2.88 667 75,800
Preexposure urinary 1-naphthol (ng/L) 43 4,200 3.77 242 39,000
Urinary 1-naphthol (ng/L) 85 28,000b 2.26 483 127,000
Preexposure urinary 2-naphthol (ng/L) 43 4,350 3.06 424 37,900
Urinary 2-naphthol (ng/L) 85 38,400c,d 2.46 485 315,000
All statistical tests were performed on log-transformed data.
aSigniﬁcantly different from preexposure breath naphthalene levels (p < 0.0001). bSigniﬁcantly different from preexposure
urinary 1-naphthol levels (p < 0.0001). cSignificantly different from preexposure urinary 2-naphthol levels (p < 0.0001).
dSigniﬁcantly higher than urinary 1-naphthol levels (p < 0.0001).Regression analysis for urinary naphthol
levels of entrants using end-exhaled breath
naphthalene as an inhalation marker
(model 2). Because the fuel-cell maintenance
workers wore respiratory protection when
entering the fuel cell, breathing-zone naphtha-
lene could be regarded as an unreliable measure
of personal inhalation exposure, because it most
likely represents an overestimation of the per-
sonal inhalation exposure under these condi-
tions. Thus, end-exhaled breath naphthalene
measured immediately after the end of work
was investigated as a potential inhalation
marker in model 2. This model explained
31.8% and 30.9% of total variance in urinary
1- and 2-naphthol levels, respectively (Table 2).
For urinary 1-naphthol, breath naphthalene
and smoking were the only signiﬁcant predic-
tors, explaining 87.2% and 12.8% of total vari-
ance, respectively. For urinary 2-naphthol,
dermal and breath naphthalene and smoking
were signiﬁcant predictors, explaining 32.3%,
52.9%, and 14.8% of total variance, respec-
tively. These results also suggest that dermal
exposure to naphthalene contributes signifi-
cantly to urinary 2-naphthol levels but not to
urinary 1-naphthol levels. Although the relative
contribution of dermal naphthalene to urinary
2-naphthol levels decreased in model 2 relative
to model 1, this may be attributed to the fact
that breath naphthalene may actually reflect
both dermal and inhalation exposure to JP-8.
Discussion
Urinary biomarkers have been widely used for
assessing exposure from all relevant exposure
routes. For JP-8 exposure, urinary 1- and
2-naphthols have previously been used as bio-
markers of exposure (Serdar et al. 2004). Using
quantitative measures, we investigated the con-
tributions of dermal and inhalation exposure to
JP-8 to urinary naphthols levels. As expected, all
postexposure measurements, including breath
naphthalene and urinary 1- and 2-naphthol,
were significantly greater than preexposure
measurements (p < 0.0001). Interestingly, we
also observed greater postexposure urinary
2-naphthol levels than postexposure urinary
1-naphthol levels (p < 0.0001). Our statistical
analyses indicate that dermal exposure to JP-8
contributed signiﬁcantly to urinary 2-naphthol
levels but not to urinary 1-naphthol levels in
both model 1 and model 2 (Table 2). This dif-
ference in ﬁndings may be due to naphthalene
metabolism in the skin by mixed-function
oxygenases and conjugation enzymes, which
may result in a proportional difference between
urinary 1- and 2-naphthol levels. Like liver,
skin contains phase 1 and phase 2 enzymes,
which are capable of detoxifying xenobiotics
(Pendlington et al. 1994). Depending upon
exposure pathway and dose, the spectrum and
abundance of metabolites may change because
of inductive capacity and saturation kinetics of
different pathways of metabolism (Henderson
et al. 1989; Lee et al. 2000). Because the spec-
trum of constitutive and inducible enzymes in
the skin is unknown, further metabolism and
toxicokinetic studies are warranted to investi-
gate naphthalene metabolism involving various
mixed-function oxygenases and conjugation
enzymes and their relative spectrums. Overall,
the impact of smoking on urinary 1- and
2-naphthol levels was minimal (11.8–14.8%)
compared with dermal and inhalation exposure
to JP-8. These results demonstrate that urinary
1- and 2-naphthol levels reflect exposure
through both dermal and inhalation routes.
Furthermore, these ﬁndings suggest that dermal
exposure to JP-8 significantly contributed to
the naphthol levels measured in urine.
Although these workers had high levels of
breathing-zone naphthalene (Table 1), their
true inhalation exposure was certainly lower,
because all workers wore air-supplied respira-
tors when working inside the fuel cells. The
use of these respirators prevented or, at the
very least, restricted inhalation exposure to
JP-8 during the task with the greatest potential
for both dermal and inhalation exposure.
With respiratory protection, breathing-zone
naphthalene can no longer be regarded as a
reliable measure of inhalation exposure for
entrants. Although breathing-zone naphtha-
lene was a significant factor contributing to
both urinary 1- and 2-naphthol levels in our
analyses, it most likely represents an overesti-
mation of the inhalation exposure level under
these conditions. To better understand the
effects of this potential overestimation of
inhalation exposure due to using breathing-
zone measurements, we used the end-exhaled
breath naphthalene measured immediately
after the end of work as a potential inhalation
marker in model 2 (Table 2). The higher R2
values in model 2 using the end-exhaled
breath naphthalene measurements provide
some evidence as to their suitability as meas-
ures of inhalation exposure. However, we have
to acknowledge that the end-exhaled breath
naphthalene levels for these workers most
likely reﬂect the contributions of both inhala-
tion and dermal exposure routes and therefore
also represent overestimations of inhalation
exposure. Nevertheless, we believe that, for the
types of workers investigated in this study, the
end-exhaled breath naphthalene level is a bet-
ter measure of inhalation exposure than is the
breathing-zone naphthalene level.
One limitation of the data set we analyzed
is that preexposure levels of urinary 1- and
2-naphthol were missing for roughly half of
our study subjects. In this data set, smoking
status is significantly associated with pre-
exposure urinary naphthol levels but not with
postexposure urinary naphthol levels. So, in
our regression analyses, we used the dichoto-
mous smoking status variable as a surrogate
for these continuous measures of preexposure
urinary naphthol levels, and we acknowledge
that this is a less than optimal strategy.
In summary, we observed that dermal
exposure to JP-8, along with inhalation expo-
sure, is a major exposure route contributing
significantly to the total body dose as mea-
sured by urinary 1- and 2-naphthol levels. We
recommend that dermal exposure monitoring
using the tape-strip technique be performed in
conjunction with biologic monitoring when
assessing exposure to JP-8. This is particularly
important when respiratory protection is used
and the potential for inhalation exposure is
limited compared with dermal exposure.
Personal protection actions and engineering
controls are needed to reduce dermal contact
with JP-8. Future studies are warranted to
understand naphthalene-specific metabolism
and the spectrum of naphthalene metabolites
in the skin and their contribution to systemic
exposure.
Chao et al.
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Table 2. Regression analyses for urinary 1- and 2-naphthol levels of fuel-cell maintenance workers when
either breathing-zone or end-exhaled breath naphthalene level was used as an inhalation marker.
Relative
Urinary Parameter contribution
metabolite No. R2 Predictor estimate SE p-Valuea (%)b
1-Naphthol 83c 0.27 Intercept 3.48 1.32 0.0101
ln(breathing-zone naphthalene) 0.50 0.10 < 0.0001 88.2
Smoking (0 = no, 1 = yes) 0.28 0.16 0.0808 11.8
72d 0.32 Intercept 6.14 0.75 < 0.0001
ln(end-exhaled breath naphthalene) 0.43 0.08 < 0.0001 87.2
Smoking (0 = no, 1 = yes) 0.36 0.17 0.0399 12.8
2-Naphthol 83c 0.26 Intercept 5.11 1.53 0.0013
ln(breathing-zone naphthalene) 0.33 0.13 0.0114 51.1
ln(dermal naphthalene) 0.11 0.04 0.0119 35.8
Smoking (0 = no, 1 = yes) 0.34 0.18 0.0603 13.1
72d 0.31 Intercept 6.80 0.87 < 0.0001
ln(end-exhaled breath naphthalene) 0.30 0.12 0.0128 52.9
ln(dermal naphthalene) 0.10 0.05 0.0790 32.3
Smoking (0 = no, 1 = yes) 0.45 0.19 0.0238 14.8
aStepwise regression variable inclusion and elimination decisions conducted at the α = 0.10 level. bEstimated using the
Pratt index (Pratt 1987). cModel 1: breathing-zone naphthalene used as an inhalation marker. dModel 2: end-exhaled
breath naphthalene used as an inhalation marker.Urinary biomarkers of dermal exposure to jet fuel
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